Solid Tumors Clinical Trials in St Louis, Missouri

4 studies are recruiting for solid tumors in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

    The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Zai Lab Site 02005, St Louis, Missouri
    Locations
    8 in total
    Run by
    Zai Lab (Shanghai) Co., Ltd.

    See if you can join NCT07374848 on ClinicalTrials.gov

  2. JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

    This study is to evaluate the efficacy and safety of JAB-30355 in adult participants with advanced solid tumors harboring TP53 Y220C mutation.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research site, St Louis, Missouri
    Locations
    15 in total
    Run by
    Jacobio Pharmaceuticals Co., Ltd.

    See if you can join NCT06386146 on ClinicalTrials.gov

  3. The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

    The purpose of this clinical trial (called the FLOTILLA study) is to give continued access to the study medicines, as well as safety follow-up, for participants in prior clinical trials of encorafenib and/or binimetinib. All participants who took part in earlier encorafenib and/or binimetinib studi…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Siteman Cancer Center, St Louis, Missouri
    Locations
    67 in total
    Run by
    Pfizer

    See if you can join NCT05203172 on ClinicalTrials.gov

  4. JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

    This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Washington University, St Louis, Missouri
    Locations
    8 in total
    Run by
    Jacobio Pharmaceuticals Co., Ltd.

    See if you can join NCT05490472 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.